Skip to main content
Premium Trial:

Request an Annual Quote

Barry Toyonaga

Premium
Traversa Therapeutics has appointed Barry Toyonaga to the position of senior vice president of business development.
 
Toyonaga will be responsible for the development and execution of global strategic partnering related to human therapeutics and high-throughput screening, the company said.
 
He previously held various positions for Johnson & Johnson, as well as its corporate venture arm, Traversa said. He has also worked in academia at institutions such as the Scripps Research Institute and the California Institute of Technology. He holds a PhD in organic chemistry from the University of Toronto.

The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.